Michael S. Diamond is a biomedical researcher, physician-scientist specializing in virology and immunology, with a particular emphasis on emerging RNA viruses such as flaviviruses, alphaviruses, and coronaviruses.
He earned his Bachelor of Arts from Columbia University and both his Doctor of Medicine and Doctor of Philosophy in Cell and Developmental Biology from Harvard Medical School and Harvard University.
[1] Diamond is also the associate director for the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs.
[2] Diamond's research focuses on emerging RNA viruses, including Zika, West Nile, chikungunya, and SARS-CoV-2, with an emphasis on understanding how these viruses cause illness and evade immune responses.
[3] Notably, in 2020, Diamond and his team developed mouse models for SARS-CoV-2, which has been instrumental in facilitating research into COVID-19 vaccines, including a nasal vaccine that was tested in mice, hamsters, and non-human primates.